Script Care Revenue and Competitors
Estimated Revenue & Valuation
- Script Care's estimated annual revenue is currently $18.7M per year.
- Script Care's estimated revenue per employee is $201,000
Employee Data
- Script Care has 93 Employees.
- Script Care grew their employee count by 7% last year.
Script Care's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Strategy Officer | Reveal Email/Phone |
2 | Chief Product Officer | Reveal Email/Phone |
3 | Chief Operating Officer, Pharmacy Division | Reveal Email/Phone |
4 | General Counsel | Reveal Email/Phone |
5 | VP Sales & Marketing | Reveal Email/Phone |
6 | VP Managed Care | Reveal Email/Phone |
7 | Director - Managed Care / 340B Programs | Reveal Email/Phone |
8 | Chief Management Officer | Reveal Email/Phone |
9 | Director Human Resources | Reveal Email/Phone |
10 | Director; Strategic Operations | Reveal Email/Phone |
Script Care Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $26.7M | 133 | 20% | N/A | N/A |
#2 | $13.5M | 67 | 6% | N/A | N/A |
#3 | $16.1M | 80 | -2% | N/A | N/A |
#4 | $62.5M | 0 | N/A | N/A | N/A |
#5 | $10.1M | 50 | 6% | N/A | N/A |
#6 | $119.4M | 594 | 27% | N/A | N/A |
#7 | $22.9M | 114 | 8% | N/A | N/A |
#8 | $92.9M | 462 | 8% | N/A | N/A |
#9 | $11.3M | 56 | -8% | N/A | N/A |
#10 | $7M | 35 | 6% | N/A | N/A |
What Is Script Care?
Script Care, Ltd. began operations as a PBM in 1986 and is the longest operating privately held PBM in the country. Today, SCL remains a family-owned company. The combination of this consistency in executive management and our maintained independence has ensured that SCL's business philosophy remains focused solely on our clients needs. Our integrated management and centralized organizational structure allows SCL to react quickly and nimbly to changing market pressures; instead of working new policies and procedures through layers of management and protocol, ideas and improvements from virtually any employment levels can be immediately evaluated by Presidents and the CEO. This adaptability was recently capitalized upon during the early stages of the creation of the Affordable Care Act (ACA); by evaluating current operating procedures and their anticipated adherence to changing policies, SCL was able to react immediately to the ACA regulations and avoid any scrambling to catch up to industry expectations. In doing so, we removed the possibility of placing additional stress on our clients as they worked through their own ACA compliance processes. Finally, not only does our structure allow for flexibility and adaptability, but our independence demands it. SCL does not have the outside revenue streams that can help fund underperformance in other PBMs (ie. investors, mail order spread, drug manufacturer revenue, etc.) Instead, our success is based solely on the satisfaction of current and future customers, ensuring continuous thought innovation, market research and a genuine focus on client satisfaction. In short, SCL's size and structure creates a company that is not only proud of our ability to offer outstanding service and products, but also one that appreciates the immediate relationship that your success has our own continued operations.
keywords:Healthcare,PharmaceuticalsN/A
Total Funding
93
Number of Employees
$18.7M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Script Care News
Like [he] really makes sure that everybody on set is taken care of and that awesome. She added: Everyone was so wonderful, I learned so much.
The product is designed to be inserted like a tampon. The founders hope to flip the script on menstruation. After a couple of their TikTok...
"We call it a care-driven marketplace. It brings together specialty drug providers, home infusion providers and payers," says Cardosi.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $19.5M | 93 | 6% | N/A |
#2 | $23.1M | 95 | 4% | N/A |
#3 | $28.4M | 98 | 0% | N/A |
#4 | $33.7M | 105 | 5% | N/A |
#5 | $31M | 107 | 8% | N/A |